Bonafide, a women’s healthcare company offering naturally powerful solutions to manage menopause has released its second State of Menopause Study, which aggregates symptoms and treatments, awareness, and societal stereotypes of over 2,000 menopausal aged women in the United States. In an effort to support women throughout their menopause journey, Bonafide is on a mission to destigmatize the topic of menopause, which is often under-discussed…
Korian, a European services Group for elderly and fragile people, and Kamet Ventures, a European Venture builder with track-record in the digital health space are partnering to invent and co-build innovative solutions for better chronic diseases management. Chronic diseases are a major public health challenge. Defined as long-term conditions with various levels of severity that may not have a cure, the diagnosis…
Los Angeles-based Pique has raised $4M in seed funding led by Maveron to further build out and continue scaling accessible, effective, sexual health care solutions for women. The company launches its first offering today targeting post-menopausal women with a holistic solution that combines medical expertise with mental, physical, hormonal, and social factors to offer patients holistic, personalized care. In the United States, 43% of…
Women’s health biotech company Oviva Therapeutics has announced an in-licensing agreement with Massachusetts General Hospital (MGH) of a family of patents, as well as $11.5M in seed funding, to develop first-in-class therapeutics to improve healthspan, the period of life spent in good health, in women. Oviva Therapeutics addresses the vast unmet need in women’s health by expanding funding, research, and clinical development of treatments…
Menopause brand Womaness has announced a new partnership with Ulta Beauty, the largest beauty retailer in the U.S. Starting today, Womaness will be sold in select Ulta Beauty stores and online. The partnership signals an important moment in retail by providing access and visibility to items that cater specifically to the needs of the 40+ woman – an often overlooked segment. Womaness…
We last spoke about Celmatix in January, when the company announced that a novel PCOS target identified as part of its five-year, multi-target alliance with Evotec has progressed into hit-identification. Now the company is back with more promising news and this time it’s about premature menopause. According to a release Celmatix has identified of a novel AMHR2 agonist compound that has demonstrated…
WILE, a hormonal wellness brand focused on women going through perimenopause has raised $3M in pre-seed funding and will debut nine SKUs in all Whole Foods Market doors this month. The round was led by Serena Ventures with participation from Springdale Ventures, angel investor Sara Bright and Coyote Ventures. The company was co-founded by Gwen Floyd, Corey Scholibo, and Julie Kucinski alongside…
Bonafide, the women’s healthcare company focused on introducing a more natural approach to managing menopause symptoms with first-of-its-kind, evidence-based, OTC medical products, has acquired a patented, enhanced formulation of S-adenosylmethionine (SAM-e), with triple the bioavailability of competitor products. This acquisition boosts Bonafide’s patent holdings to more than 50 issued and pending patents that it owns or exclusively licenses and exemplifies its strategy…
